Related Experiment Video
Updated: Oct 7, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Detection of Mycoplasma pneumoniae from cerebrospinal fluid samples of pediatric patients
1Bacteriology Division, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia.
Abstract:
Central nervous system manifestations are probably the most frequent extrapulmonary complications of infections due to Mycoplasma pneumoniae, occur mostly in children. In this study, we attempted to isolate M. pneumoniae and to detect the organism by polymerase chain reaction (PCR) from cerebrospinal fluid samples (CSF) of pediatric patients. Of the 244 CSF samples, no M. pneumoniae was isolated. Six (2.5%) of the CSF samples were positive by PCR amplification. More effort are necessary to isolate the organism from CSF samples in order to ascertain the role of M. pneumoniae in causing neurological complications.
Insights
Mycoplasma pneumoniae infections can cause central nervous system issues in children. While Mycoplasma pneumoniae was not isolated from cerebrospinal fluid (CSF), PCR detected the organism in 2.5% of samples, suggesting a potential role in neurological complications.
Area of Science:
- Pediatric neurology
- Infectious diseases
- Microbiology
Background:
- Central nervous system (CNS) manifestations are common extrapulmonary complications of Mycoplasma pneumoniae infections, particularly in children.
- Understanding the causative agent is crucial for diagnosing and managing pediatric neurological disorders.
Purpose of the Study:
- To investigate the presence of Mycoplasma pneumoniae in the cerebrospinal fluid (CSF) of pediatric patients with neurological symptoms.
- To determine the utility of culture and PCR methods for detecting Mycoplasma pneumoniae in CSF.
Main Methods:
- Cerebrospinal fluid (CSF) samples were collected from 244 pediatric patients.
- Attempted isolation of Mycoplasma pneumoniae via culture.
- Detection of Mycoplasma pneumoniae DNA using polymerase chain reaction (PCR) amplification.
Main Results:
- Mycoplasma pneumoniae was not isolated from any of the 244 CSF samples.
- PCR detected Mycoplasma pneumoniae DNA in 6 (2.5%) of the CSF samples.
- The findings indicate a low but detectable presence of the organism in CSF.
Conclusions:
- Direct isolation of Mycoplasma pneumoniae from CSF is challenging.
- PCR offers a more sensitive method for detecting Mycoplasma pneumoniae in CSF of pediatric patients with neurological complications.
- Further research is needed to confirm the role of Mycoplasma pneumoniae in pediatric neurological conditions.